Phase I-II clinical and pharmacokinetic study of irofulven in combination with oxaliplatin in patients with advanced solid tumours.

Trial Profile

Phase I-II clinical and pharmacokinetic study of irofulven in combination with oxaliplatin in patients with advanced solid tumours.

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 06 Jun 2017

At a glance

  • Drugs Irofulven (Primary) ; Oxaliplatin (Primary)
  • Indications Endometrial cancer; Gastric cancer; Liver cancer; Pancreatic cancer; Solid tumours
  • Focus Therapeutic Use
  • Sponsors Eisai Inc
  • Most Recent Events

    • 09 Mar 2009 Planned end date (Aug 2007) added as reported by ClinicalTrials.gov.
    • 06 Mar 2009 Additional lead trial centre identified as reported by ClinicalTrials.gov, last updated 6 Mar 2009.
    • 06 Mar 2009 Patient number amended from 70 to 63 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top